Cita APA (7a ed.)

W, L., Y, M., X, Z., Y, W., J, W., S, Z., . . . M, Z. (2019). RGDV-modified gemcitabine: A nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine. Dove Medical Press.

Cita Chicago Style (17a ed.)

W, Liu, Mao Y, Zhang X, Wang Y, Wu J, Zhao S, Peng S, y Zhao M. RGDV-modified Gemcitabine: A Nano-medicine Capable of Prolonging Half-life, Overcoming Resistance and Eliminating Bone Marrow Toxicity of Gemcitabine. Dove Medical Press, 2019.

Cita MLA (8a ed.)

W, Liu, et al. RGDV-modified Gemcitabine: A Nano-medicine Capable of Prolonging Half-life, Overcoming Resistance and Eliminating Bone Marrow Toxicity of Gemcitabine. Dove Medical Press, 2019.